logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
04/06/2025
UBS: Maintains rating on Duke Energy (DUK.US) at Neutral, with target price adjusted from $126.00 to $127.00.
Latest
3 m ago
ThyssenKrupp's stock price increase has widened and is expected to achieve the largest single-day increase since March, currently up by 10.1%.
4 m ago
A source close to the legal proceedings said that an Italian court has delayed the judgment on the appeal of Yuexin Bank until July 9th.
4 m ago
JieXin Consumer Finance has officially changed its name to JD Consumer Finance.
4 m ago
Tianchen Co., Ltd: Investing to establish a wholly-owned subsidiary with a registered capital of 40 million yuan.
5 m ago
Baike Biotechnology (688276.SH): Clinical trial application for recombinant herpes zoster vaccine (CHO cells) approved
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.